PPT-Why do/should we do economic evaluation?

Author : danika-pritchard | Published Date : 2016-12-20

Tony Culyer Universities of Toronto and York UK A simpleminded economists approach Lets suppose I run an integrated health insurance and care program could be

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Why do/should we do economic evaluation?" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Why do/should we do economic evaluation?: Transcript

Tony Culyer Universities of Toronto and York UK A simpleminded economists approach Lets suppose I run an integrated health insurance and care program could be public or private but lets say public. It may be accessed via the Value in Health or via the ISPOR Health Economic Evaluation Publicat ion Guidelines CHEERS Good Reporting Practices webpage httpwwwispororgTaskForcesEconomicPubGuidelinesasp Sectionitem Item No Recommendation Reported on Fattore. a. , Francesca . Ferrè. a. , Michela . Meregaglia. a. , . Elena . Fattore. b. , Carlo . Agostoni. c. a. CERGAS. Università Bocconi, Milano. b. department. of . Environmental. . Health. . , F.H., andL, R.A.F., andF, R.J. andV, R.J. andV, R.J. andV, R.J. andV, R.J. andV.Guidelines For The Cost Effective Use And Application JULY 2007 VOLUME 107 REFEREED PAPER The Journal of Tuesday, january 14, 2014, 11:00 . AM . -12:15 . PM. Barbara A. Myers, CAE. Vice President of Professional Development, International Society of . Pharmaceutical Engineering . (ISPE). Kevin Miller. President, Frost Miller Group. From . Republic of Science to . Audit . Society, . Irwin . Feller. S. . Charlot. ASIRPA. , . Paris. , . France; June . 13, 2012. Outline. New . Questions/Issues & What’s at Stake . How . They’re Answered?. Guettabi, PhD. Assistant Professor of Economics, Institute of Social and Economic Research. January . 28, . 2015 . Anchorage. What motivates people to act the way they do?. “Economics surely does not provide a romantic vision of life. But the widespread poverty, misery, and crises in many parts of the world, much of it unnecessary, are strong reminders that understanding economic and social laws can make an enormous contribution to the welfare of people. ". Shelley O’Neill. Health . Technology . Assessment Directorate. Presentation outline. Introduction to Health Technology Assessment (HTA). NCEC guideline prioritisation criteria. Conducting a budget impact assessment. Link to syllabus. Figure 12.1 page 260. Types of economic blocs. Asean. Countries. (Significant overlap with APEC). FTAs in Latin America. LAFTA. 1960s. Andean. Pact. Central American Common Market. Pathways. Xin Zhao, Purdue University. Dr. Tristan . R. . Brown, SUNY-ESF . Dr. Wallace . E. . Tyner, Purdue University. 1. Cellulosic Biofuels. Cellulosic biofuels . are . produced from . lignocellulosic. Richard Smith. Reader in Health Economics. School of Medicine, Health Policy & Practice. Overview of lecture. What is antimicrobial resistance (AMR)?. Economic conceptualisation of AMR. Cost of resistance - country, hospital, disease. Tzeyu Michaud, PhD . Department of Health Promotion, Social, & Behavioral Health. UNMC. Overview. What is economic evaluations?. Why conduct economic evaluations?. Review of economic evaluations. Denny John. Evidence Synthesis Specialist, Campbell Collaboration. Acknowledgement: Dr. Luke Vale, Professor- Health Economics, Newcastle University, UK. Designing essential package of services- Context of UHC. 413-535-4485 | . thelwick@iso-ne.com. 413-535-4012| . gbradley@iso-ne.com. 1. Permanent and Retirement De-List Bids Compliance eTariff Filing. Rehearing Order Directing Corrections to Economic Life Revisions Tariff Language. Dr. Haider Raheem Mohammad. Pharmacoeconomics – What is it?. In the case of pharmaceutical interventions, pharmacoeconomics attempts to find . whether the added benefit of one intervention is worth the added cost of that intervention.

Download Document

Here is the link to download the presentation.
"Why do/should we do economic evaluation?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.